EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparative Genomic Profiling and Prognostic Impact in Recurrent and/or Metastatic Hypopharyngeal and Esophageal Squamous Cell Carcinoma

Hiromi Nagano iD, Satoshi Kiyama, Takayuki Kyutoku iD, Hayato Matsumoto iD, Masaru Yamashita

Laryngoscope Investigative Otolaryngology · 2026-06 · 11 (3)

DOI: 10.1002/lio2.70459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngoscope Investigative Otolaryngology, online erschienen am 02.06.2026. Verfasst von Hiromi Nagano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery Kagoshima University Graduate School of Medical and Dental Sciences Kagoshima Japan. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to characterize the mutational profile of recurrent and/or metastatic esophageal squamous cell carcinoma (ESCC) and hypopharyngeal squamous cell carcinoma (HPSCC).

Methods

Data from 1319 consecutive patients with ESCC and 195 patients with HPSCC registered in the Center for Cancer Genomics and Advanced Therapeutics (C‐CAT) at the Japan National Cancer Center between June 2019 and October 2025 were analyzed. Genetic alterations were identified using next‐generation sequencing. Patient survival was analyzed using the log‐rank test and the Cox proportional hazards model.

Results

TP53 , CDKN2A/B , CCND1 , and FGF family genes were frequently mutated in both ESCC and HPSCC, with a comparable number of mutations per individual. Comparative analysis revealed that only NFE2L2 ( p = 2.9 × 10 −6 ) mutations were significantly more frequent in ESCC after FDR correction. Survival analyses demonstrated that CCND1 ( p = 5.8 × 10 −3 ), FGF3 ( p = 8.66 × 10 −3 ), FGF4 ( p = 3.89 × 10 −3 ), FGF19 ( p = 8.75 × 10 −3 ), and NFE2L2 ( p = 8.75 × 10 −3 ) mutations were significantly associated with poorer overall survival in ESCC, whereas distinct prognostic impacts were observed in HPSCC.

Conclusions

ESCC and HPSCC shared broadly similar mutational landscapes; however, NFE2L2 mutations were significantly enriched in ESCC. Moreover, alterations in CCND1 and FGF family genes were associated with poor prognosis, highlighting their potential roles as prognostic biomarkers and therapeutic targets in ESCC. Level of Evidence III.

Schlagwörter

Stichwörter der Autor:innen

TP53cancer genomic profiling testsesophageal squamous cell carcinomagenetic mutationshypopharyngeal squamous cell carcinoma

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery Kagoshima University Graduate School of Medical and Dental Sciences Kagoshima Japan.

ORCID-Profile: Hiromi Nagano, Takayuki Kyutoku, Hayato Matsumoto

Zitieren

APA

Nagano, H., Kiyama, S., Kyutoku, T., Matsumoto, H., & Yamashita, M. (2026). Comparative Genomic Profiling and Prognostic Impact in Recurrent and/or Metastatic Hypopharyngeal and Esophageal Squamous Cell Carcinoma. Laryngoscope Investigative Otolaryngology, 11(3). https://doi.org/10.1002/lio2.70459

Vancouver

Nagano H, Kiyama S, Kyutoku T, Matsumoto H, Yamashita M. Comparative Genomic Profiling and Prognostic Impact in Recurrent and/or Metastatic Hypopharyngeal and Esophageal Squamous Cell Carcinoma. Laryngoscope Investigative Otolaryngology. 2026;11(3). doi:10.1002/lio2.70459

BibTeX
@article{Nagano2026,
  author = {Nagano, Hiromi and Kiyama, Satoshi and Kyutoku, Takayuki and Matsumoto, Hayato and Yamashita, Masaru},
  title = {Comparative Genomic Profiling and Prognostic Impact in Recurrent and/or Metastatic Hypopharyngeal and Esophageal Squamous Cell Carcinoma},
  journal = {Laryngoscope Investigative Otolaryngology},
  year = {2026},
  volume = {11},
  number = {3},
  doi = {10.1002/lio2.70459}
}
Kostenlos starten →